JURVIGO

Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation

Educational services, namely, lectures, seminars, training and classes in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; education, namely, lectures, seminars, classes and training in the use of pharmaceuticals for cardiac and other health issues

Medical and pharmaceutical research for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease research, namely, single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others

Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes